• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于胸部CT的人工智能模型在鉴别肺毛霉病、侵袭性肺曲霉病和肺结核中的性能

Performance of Chest CT-Based Artificial Intelligence Models in Distinguishing Pulmonary Mucormycosis, Invasive Pulmonary Aspergillosis, and Pulmonary Tuberculosis.

作者信息

Li Yun, Chen Deyan, Zhang Youwen, Liu Shuyi, Liang Lina, Tan Lunfang, Yang Fan, Li Yuyan, Peng Chengbao, Ye Feng, Zhang Xia, Hu Guodong, Chen Huai, Zheng Jinping

机构信息

National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Neusoft Research of Intelligent Healthcare Technology, Co. Ltd, Shenyang, China.

出版信息

Med Mycol. 2025 Jan 6. doi: 10.1093/mmy/myae123.

DOI:10.1093/mmy/myae123
PMID:39762132
Abstract

In clinical practice, differentiating among pulmonary mucormycosis (PM), invasive pulmonary aspergillosis (IPA), and pulmonary tuberculosis (PTB) can be challenging. This study aimed to evaluate the performance of chest CT-based artificial intelligence (AI) models in distinguishing among these three diseases. Patients with confirmed PM, IPA, or PTB were retrospectively recruited from three tertiary hospitals. Two models were developed: unanotated supervised training (UST) model trained with original CT images and annotated supervised training (AST) model trained with manually annotated lesion images. A network questionnaire with 20 cases was designed to assess the performance of clinicians. Sensitivity, specificity, and accuracy were calculated for both models and clinicians. A total of 61 PM cases, 136 IPA cases, and 155 PTB cases were included in the study. In the internal validation set, both models had an accuracy of 66.1%. The UST model had sensitivities of 27.3%, 73.9%, and 76.0% for PM, IPA, and PTB, while AST model had sensitivities of 9.1%, 69.6%, and 88.0% for the same conditions. In the external validation set, both models had an accuracy of 57.6%. The UST model had sensitivities of 0, 85.7%, and 53.3% for PM, IPA, and PTB, respectively, while AST model had sensitivities of 0, 42.9% and 83.3%. 112 clinicians had an accuracy of 42.9%, with sensitivities of 31.5%, 43.4%, and 48.0% for PM, IPA, and PTB. We demonstrated that two AI models showed comparable performance in diagnosing three diseases. Both models achieved acceptable sensitivity in detecting IPA and PTB, but had low sensitivity in identifying PM.

摘要

在临床实践中,区分肺毛霉菌病(PM)、侵袭性肺曲霉病(IPA)和肺结核(PTB)具有挑战性。本研究旨在评估基于胸部CT的人工智能(AI)模型在区分这三种疾病方面的性能。从三家三级医院回顾性招募确诊为PM、IPA或PTB的患者。开发了两种模型:用原始CT图像训练的无注释监督训练(UST)模型和用手动注释的病变图像训练的注释监督训练(AST)模型。设计了一份包含20个病例的网络问卷来评估临床医生的表现。计算了两种模型和临床医生的敏感性、特异性和准确性。本研究共纳入61例PM病例、136例IPA病例和155例PTB病例。在内部验证集里,两种模型的准确率均为66.1%。UST模型对PM、IPA和PTB的敏感性分别为27.3%、73.9%和76.0%,而AST模型在相同情况下的敏感性分别为9.1%、69.6%和88.0%。在外部验证集中,两种模型的准确率均为57.6%。UST模型对PM、IPA和PTB的敏感性分别为0、85.7%和53.3%,而AST模型的敏感性分别为0、42.9%和83.3%。112名临床医生的准确率为42.9%,对PM、IPA和PTB的敏感性分别为31.5%、43.4%和48.0%。我们证明,两种AI模型在诊断这三种疾病方面表现相当。两种模型在检测IPA和PTB方面都达到了可接受的敏感性,但在识别PM方面敏感性较低。

相似文献

1
Performance of Chest CT-Based Artificial Intelligence Models in Distinguishing Pulmonary Mucormycosis, Invasive Pulmonary Aspergillosis, and Pulmonary Tuberculosis.基于胸部CT的人工智能模型在鉴别肺毛霉病、侵袭性肺曲霉病和肺结核中的性能
Med Mycol. 2025 Jan 6. doi: 10.1093/mmy/myae123.
2
Supervised training models with or without manual lesion delineation outperform clinicians in distinguishing pulmonary cryptococcosis from lung adenocarcinoma on chest CT.在胸部 CT 上,有或没有手动病变勾画的监督训练模型在区分肺隐球菌病和肺腺癌方面优于临床医生。
Mycoses. 2024 Jan;67(1):e13692. doi: 10.1111/myc.13692.
3
Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis.肺部毛霉菌病和侵袭性肺曲霉病的 CT 表现比较。
Clin Microbiol Infect. 2015 Jul;21(7):684.e11-8. doi: 10.1016/j.cmi.2015.03.019. Epub 2015 Apr 13.
4
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training.基于深度学习和大数据训练的侵袭性肺曲霉病早期诊断原型模型
Mycoses. 2023 Feb;66(2):118-127. doi: 10.1111/myc.13540. Epub 2022 Oct 31.
5
Comparison of Clinical Manifestation, Diagnosis, and Outcomes of Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis.侵袭性肺曲霉病与肺毛霉病的临床表现、诊断及转归比较
Microorganisms. 2019 Nov 5;7(11):531. doi: 10.3390/microorganisms7110531.
6
Invasive Pulmonary Aspergillosis-mimicking Tuberculosis.侵袭性肺曲霉病样肺结核。
Clin Infect Dis. 2015 Jul 1;61(1):9-17. doi: 10.1093/cid/civ216. Epub 2015 Mar 16.
7
Using artificial intelligence to assist radiologists in distinguishing COVID-19 from other pulmonary infections.利用人工智能辅助放射科医生区分 COVID-19 与其他肺部感染。
J Xray Sci Technol. 2021;29(1):1-17. doi: 10.3233/XST-200735.
8
Deep Learning Model for Diagnosing and Classifying Subtypes of Chronic Pulmonary Aspergillosis in Chest CT.用于胸部CT中慢性肺曲霉病亚型诊断和分类的深度学习模型
Mycoses. 2025 Apr;68(4):e70061. doi: 10.1111/myc.70061.
9
Clinic, CT radiomics, and deep learning combined model for the prediction of invasive pulmonary aspergillosis.联合临床、CT 放射组学和深度学习模型预测侵袭性肺曲霉病。
BMC Med Imaging. 2024 Oct 7;24(1):264. doi: 10.1186/s12880-024-01442-x.
10
A fully automatic artificial intelligence-based CT image analysis system for accurate detection, diagnosis, and quantitative severity evaluation of pulmonary tuberculosis.一种基于全自动人工智能的 CT 图像分析系统,用于准确检测、诊断和定量评估肺结核的严重程度。
Eur Radiol. 2022 Apr;32(4):2188-2199. doi: 10.1007/s00330-021-08365-z. Epub 2021 Nov 29.

引用本文的文献

1
Invasive Mucormycosis in a Chronic Lymphocytic Leukemia Patient on Zanubrutinib: A Case Report.一例接受泽布替尼治疗的慢性淋巴细胞白血病患者发生侵袭性毛霉病:病例报告
Infect Drug Resist. 2025 Jul 4;18:3281-3287. doi: 10.2147/IDR.S526660. eCollection 2025.
2
Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018-2023).临床和环境毛霉目真菌的分子流行病学、多样性及抗真菌药敏谱:伊朗一项为期五年的多中心研究(2018 - 2023年)
BMC Infect Dis. 2025 Jul 1;25(1):849. doi: 10.1186/s12879-025-11189-7.